Dr. Luciana Borio serves as the Assistant Commissioner for Counterterrorism Policy and Director of the Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist, U.S. Food and Drug Administration (FDA). In this capacity, Dr. Borio is responsible for providing leadership, coordination, and oversight for FDA’s national and global health security, counterterrorism, and emerging threat portfolios. She serves as FDA’s point of entry on policy and planning matters concerning counterterrorism and emerging threats, including Ebola, and collaborates across the U.S. government and internationally on actions to advance global health security and U.S. national security. She also serves as FDA’s Acting Chief Scientist, responsible for providing leadership and coordination for FDA's cross-cutting scientific and public health efforts.
Prior to joining FDA as a medical reviewer in 2008, Dr. Borio served as a Senior Associate at the UPMC Center for Biosecurity, Assistant Professor of Medicine at the University of Pittsburgh, and Advisor on Biodefense Programs for the U.S. Department of Health and Human Services. Dr. Borio received her MD from the George Washington University, and continues to practice medicine at Johns Hopkins Hospital.